Evaluation of Emergency Suturing With Absorbable Versus Non-absorbable Suture Material in a Pediatric Population

July 1, 2025 updated by: Giorgio La Scala, Pediatric Clinical Research Platform

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

Outcomes are:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Study Overview

Status

Completed

Conditions

Detailed Description

The investigators recruit patients admitted to the Pediatric Emergency Department of the Geneva's University Hospital with open wounds needing suture. The patients are treated with absorbable versus non-absorbable suture material according to randomization.

After obtaining the patient's/parent's consent and randomization, the suture material will be provided.

Selection of the size of the thread and the date of the first follow-up are determined as follows:

  • Face: Thread size 5-0 to 7-0, first follow-up 4-7 days
  • Torso/back: Thread size 4-0 or 5-0, first follow-up 10-14 days
  • Arms: Thread size 4-0 or 5-0, first follow-up 7- 10 days
  • Hand: Thread size 5-0 or 6-0, first follow-up 7-10 days
  • Legs: Thread size 4-0 or 5-0, first follow-up 7-14 days

The patients are examined by in the outpatient wound clinic by specialised nurses under medical supervision at the first follow-up, and at six months by one of the investigators.

Outcomes:

  1. infection rate at the first follow-up (between 4 and 14 days, depending on the sutured site and defined by protocol)
  2. scar appearance at a 6-months follow-up.

Study Type

Interventional

Enrollment (Actual)

550

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Genève
      • Geneve, Genève, Switzerland, 1205
        • Geneva University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 day to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient younger than 16 years of age with a wound requiring suture

Exclusion Criteria:

  • Deep wounds with lesions of subcutaneous structures (tendons, nerves, etc.)
  • Wounds with tissue loss
  • Diabetic patients or patients treated with drugs potentially compromising cicatrization (e.g. steroids, immunosuppressors, etc.)
  • Wounds caused by animal or human bites
  • Sutures not performed in the emergency room
  • Heavily soiled wounds

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Absorbable
Suture material: Polyglactin 910 thread (Vicryl Rapide®, Ethicon Inc).

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups.

Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

Active Comparator: Non Absorbable
Suture material: Polypropylene thread (Prolene®, Ethicon Inc).

Wound suture by a resident physician. Two follow-up appointments (first at 4 to 21 days after the suture, according to the sutured site as defined by protocol, second at 6 months) Standardized photography of the wound before the suture and at the two subsequent follow-ups.

Evaluation of the scar with a standardised form by a specialised nurse under medical supervision at the first follow-up and by a panel of investigators at 6 months using the pictures taken at the follow-up appointments.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Short-term infection risk
Time Frame: 4 to 21 days
Scars classified as "no evidence of infection", "signs of inflammation" and "signs of active infection"
4 to 21 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Scar appearance
Time Frame: 6 months
Scoring based on the Manchester scar scale
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Giorgio La Scala, MD PD, University Hospital, Geneva

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2016

Primary Completion (Actual)

February 6, 2025

Study Completion (Actual)

February 6, 2025

Study Registration Dates

First Submitted

May 17, 2016

First Submitted That Met QC Criteria

May 18, 2016

First Posted (Estimated)

May 19, 2016

Study Record Updates

Last Update Posted (Actual)

July 4, 2025

Last Update Submitted That Met QC Criteria

July 1, 2025

Last Verified

July 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Wounds and Injuries

Clinical Trials on Absorbable

Subscribe